Showing results (141-150 of 159) with videos related to
Sort By:
Pageof 16
Scientific Reports|August 25, 2017
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBLYi-Hung Carol Tan, Tamara Mirzapoiazova, Brian M Won, et al.Genes, Chromosomes & Cancer|May 16, 2012
Differential expression of RON in small and non-small cell lung cancersRajani Kanteti, Soundararajan Krishnaswamy, Daniel Catenacci, et al.Plos One|September 22, 2010
A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancerYen-An Tang, Wei-Ling Wen, Jer-Wei Chang, et al.Scientific Reports|June 16, 2015
Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung CancerBenjamin D Ferguson, Yi-Hung Carol Tan, Rajani S Kanteti, et al.BMJ Health & Care Informatics|August 8, 2024
Perspectives on telemedicine across urban, rural and remote areas in the Philippines during the COVID-19 pandemicNoleen Fabian, Regine Ynez De Mesa, Carol Tan-Lim, et al.Oncotarget|June 1, 2016
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinomaCleo E Rolle, Yi-Hung Carol Tan, Tanguy Y Seiwert, et al.International Journal of Surgery (London, England)|December 17, 2025
Clinical efficacy of surgical sealants after pulmonary resection: an individual patient data meta-analysis of randomized controlled trialsMatthew Shiu Hang Wong, Vinci Naruka, Paulo De Sousa, et al.International Journal of Oncology|April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell linesTamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.Cancer Biology & Therapy|October 13, 2018
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesotheliomaJiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|June 24, 2017
ANGPTL4 T266M variant is associated with reduced cancer invasivenessZhen Wei Tan, Ziqiang Teo, Carol Tan, et al.Pageof 16